Background: Programmed death-ligand 1 (PD-L1) has been determined as a reliable prognostic factor for various malignancies. In this study, we aimed to determine the prognostic effect of PD-L1 expression in tumor-infiltrating immune cells (TIICs) of nasopharyngeal carcinoma (NPC) patients.Methods: Seventy patients diagnosed with non-metastatic NPC were included in the study. PD-L1 expression on immune cells was analyzed by immunohistochemical method. Patients were categorized into two groups according to the PD-L1 expression level in TIICs (level of PD-L1 staining ≥5% positive vs <5% negative).Results: Median follow-up period was 34 months (range = 1 - 188). 1 and 2 years survival rate were found as 75% and 63% in PD-L1 negative TIICs group ...
Programmed death-ligand 1 (PD-L1) is a promising target of cancer immune therapy. It not only expres...
Introduction: For several years non-small cell lung cancer (NSCLC) has been considered non-immunogen...
Background: Immunotherapy can become a crucial therapeutic option to improve prognosis for lung canc...
Increased Expression of PD-L1 in Undifferentiated Non Keratinizing Squamous Cell Carcinoma Naso...
Background: Programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) expression is associated...
Introduction: The aim of this study was to evaluate the expression of PD-L1 in oropharyngeal squamou...
The prognostic value of programmed death-ligand 1 (PD-L1) expression in nasopharyngeal carcinoma (NP...
[[abstract]]Intratumoral cytotoxic T lymphocytes are critical for controlling tumor recurrence, and ...
Background: Programmed death-ligand 1 (PD-L1) is an immune checkpoint that is primarily located on ...
To investigate the expression of programmed death-ligand 1 (PD-L1) and immune checkpoints and their ...
Background: Programmed death-ligand 1 (PD-L1) is an immune checkpoint that is primarily located on t...
Background: Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer. Prior to the advent of...
Objectives: Immune checkpoint blockade using inhibitors of programmed death-1 have shown promise in ...
BACKGROUND:Programmed cell death ligand-1 (PD-L1) expression on tumor cells (TCs) is associated with...
Linfeng Zheng,1,* Caineng Cao,2,3,* Guoping Cheng,1 Qiaoying Hu,2,3 Xiaozhong Chen2,3 1Department o...
Programmed death-ligand 1 (PD-L1) is a promising target of cancer immune therapy. It not only expres...
Introduction: For several years non-small cell lung cancer (NSCLC) has been considered non-immunogen...
Background: Immunotherapy can become a crucial therapeutic option to improve prognosis for lung canc...
Increased Expression of PD-L1 in Undifferentiated Non Keratinizing Squamous Cell Carcinoma Naso...
Background: Programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) expression is associated...
Introduction: The aim of this study was to evaluate the expression of PD-L1 in oropharyngeal squamou...
The prognostic value of programmed death-ligand 1 (PD-L1) expression in nasopharyngeal carcinoma (NP...
[[abstract]]Intratumoral cytotoxic T lymphocytes are critical for controlling tumor recurrence, and ...
Background: Programmed death-ligand 1 (PD-L1) is an immune checkpoint that is primarily located on ...
To investigate the expression of programmed death-ligand 1 (PD-L1) and immune checkpoints and their ...
Background: Programmed death-ligand 1 (PD-L1) is an immune checkpoint that is primarily located on t...
Background: Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer. Prior to the advent of...
Objectives: Immune checkpoint blockade using inhibitors of programmed death-1 have shown promise in ...
BACKGROUND:Programmed cell death ligand-1 (PD-L1) expression on tumor cells (TCs) is associated with...
Linfeng Zheng,1,* Caineng Cao,2,3,* Guoping Cheng,1 Qiaoying Hu,2,3 Xiaozhong Chen2,3 1Department o...
Programmed death-ligand 1 (PD-L1) is a promising target of cancer immune therapy. It not only expres...
Introduction: For several years non-small cell lung cancer (NSCLC) has been considered non-immunogen...
Background: Immunotherapy can become a crucial therapeutic option to improve prognosis for lung canc...